|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 927.03 USD | +2.55% |
|
-1.32% | -13.74% |
| 04-17 | Health Care Up Ahead of Earnings - Health Care Roundup | DJ |
| 04-17 | Kailera makes a splash on Nasdaq as anti-obesity drug frenzy continues |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 27.53x | 17.01x | 0.59x | 10.33x | 20.7x | 22.52x | 0.73% | 830B | ||
| 25.1x | 6.3x | -1.63x | 5.77x | 15.66x | 17.35x | 2.28% | 564B | ||
| 23.45x | 139.59x | 0.08x | 6.27x | 12.73x | 13.11x | 3.32% | 369B | ||
| 25.85x | 5.7x | 1.22x | 5.33x | 15.06x | 15.92x | 1.62% | 318B | ||
| 21.14x | 6.38x | 1104.47x | 5.67x | 13.72x | 15x | 2.89% | 291B | ||
| 28.18x | 5.23x | -0.67x | 4.9x | 15.22x | 18.06x | 2.84% | 294B | ||
| 23.82x | 16.98x | 4.96x | 6.15x | 10.83x | 13.99x | 2.83% | 192B | ||
| 12.34x | 5.22x | -1.48x | 4.43x | 9.26x | 10.9x | 4.19% | 182B | ||
| 18.69x | 6.18x | 2.17x | 5.84x | 10.76x | 12.64x | 2.36% | 171B | ||
| 12.49x | 1.78x | 0.2x | 3.31x | 7.96x | 9.32x | 6.36% | 157B | ||
| 12.27x | 5.22x | 0.29x | 3.2x | 8.43x | 9.24x | 4.2% | 123B | ||
| 12x | 1.28x | 1.78x | 2.35x | 7.54x | 8.31x | 5.19% | 117B | ||
| 13.56x | 4.44x | 1.13x | 2.88x | 8.46x | 9.53x | 3.26% | 116B | ||
| 25.2x | 4.99x | 1.77x | 7.62x | 17.17x | 17.74x | -.--% | 112B | ||
| 27.13x | 6.05x | 1.63x | 9.26x | 17.41x | 18.2x | 1.64% | 86.92B | ||
| 49.99x | 1.24x | 0.79x | 2.82x | 10.4x | 29.53x | 3.58% | 55.82B | ||
| 40.09x | 5.39x | 2.1x | 9.07x | 30.34x | 33.11x | 0.48% | 54.77B | ||
| 20.53x | 1.45x | -0.13x | 1.6x | 7.7x | 13.21x | 0.52% | 47.67B | ||
| 18.58x | 1.87x | 4.3x | 3.4x | 12.84x | 14.4x | 2.2% | 43.3B | ||
| Average | 23.05x | 12.75x | 59.13x | 5.27x | 13.27x | 15.90x | 2.66% | 217.02B | |
| Weighted average by Cap. | 23.45x | 20.07x | 78.38x | 6.30x | 14.63x | 16.45x | 2.43% |
- Stock Market
- Equities
- LLY Stock
- Sector Eli Lilly and Company
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















